Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 16:59:54 UTC 2023
by
admin
on
Sat Dec 16 16:59:54 UTC 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
TN9BEX005G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
B01AE06
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
||
|
FDA ORPHAN DRUG |
200204
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
||
|
NDF-RT |
N0000175980
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
||
|
NDF-RT |
N0000175518
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
||
|
NCI_THESAURUS |
C263
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000085243
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
TN9BEX005G
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
1076013
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
SUB05862MIG
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
385
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
m2581
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
DB00006
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
128270-60-0
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
FF-67
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
59173
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
C47415
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
TN9BEX005G
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
Bivalirudin
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
DTXSID00155847
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
7282
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
Bivalirudin
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY | |||
|
60819
Created by
admin on Sat Dec 16 16:59:55 UTC 2023 , Edited by admin on Sat Dec 16 16:59:55 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||